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Abstract 25 
Knowledge of the complement of cytochrome P450 (CYP) genes is essential to understanding 26 
detoxification and bioactivation mechanisms for organic contaminants.We cloned three new 27 
CYP1 genes, CYP1B1, CYP1C2 and CYP1D1, from the killifish Fundulus heteroclitus, an 28 
important model in environmental toxicology.  Expression of the new CYP1s along with 29 
previously known CYP1A and CYP1C1 was measured by qPCR in eight different organs. Organ 30 
distribution was similar for the two CYP1Cs, but otherwise patterns and extent of expression 31 
differed among the genes. The AHR agonist 3,3_,4,4_,5-pentachlorobiphenyl (PCB126) (31 32 
pmol/g fish) induced expression of CYP1A and CYP1B1 in all organs examined, while CYP1C1 33 
was induced in all organs except testis. The largest changes in response to PCB126 were 34 
induction of CYP1A in testis (700-fold) and induction of CYP1C1 in liver (500-fold). CYP1B1 35 
in liver and gut, CYP1A in brain and CYP1C1 in gill also were induced strongly by PCB126 36 
(>100-fold). CYP1C1 expression levels were higher than CYP1C2 in almost all tissues and 37 
CYP1C2 was much less responsive to PCB126. In contrast to the other genes, CYP1D1 was not 38 
induced by PCB126 in any of the organs. The organ-specific response of CYP1s to PCB126 39 
implies differential involvement in effects of halogenated aromatic hydrocarbons in different 40 
organs. The suite of inducible CYP1s could enhance the use of F. heteroclitus in assessing 41 
aquatic contamination by AHR agonists. Determining basal and induced levels of protein and the 42 
substrate specificity for all five CYP1s will be necessary to better understand their roles in 43 
chemical effects and physiology.44 
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1. Introduction 45 
Cytochrome P450 (CYP) enzymes catalyze oxidative metabolism of thousands of drugs, 46 
environmental pollutants, and endogenous compounds. Environmental pollutants such as 47 
halogenated hydrocarbons, polycyclic aromatic hydrocarbons (PAH), herbicides, and pesticides 48 
(Nebert and Russell, 2002) include many substrates of mammalian CYP1s (CYP1A1, CYP1A2, 49 
CYP1B1), and of fish CYP1As (e.g., Schober et al., 2006).  While metabolism often results in 50 
detoxification, the action of CYP1 enzymes also can generate toxic metabolites that contribute to 51 
increased risks of cancer, birth defects, and other toxic effects (Nebert and Karp, 2008).  52 
Expression of mammalian CYP1A1 and fish CYP1As can be induced strongly by PAH, planar 53 
polychlorinated biphenyl (PCB), dibenzo-p-dioxin (PCDD), and dibenzofuran (PCDF) 54 
congeners, and some natural products, via activation of aryl hydrocarbon receptor (AHR) (Hahn, 55 
2002). These features have led to widespread use of CYP1A gene expression as a marker of 56 
environmental exposure to AHR agonists in humans and wildlife (e.g., Stegeman, 1986; Fujita et 57 
al., 2001; Lambert et al., 2006).  58 
Most fish have only one CYP1A gene and one CYP1B1 gene (Goldstone et al., 2007). 59 
Fish also have two CYP1Cs, the paralogous CYP1C1 and CYP1C2 (Godard et al., 2005).  Like 60 
CYP1A and CYP1B1, the CYP1Cs are induced to varying degrees by AHR agonists in zebrafish 61 
(Jönsson et al., 2007a; Jönsson et al., 2007b).  More recently we have identified a fifth CYP1 62 
gene in teleosts, CYP1D1 (Goldstone et al., 2007; Goldstone and Stegeman, 2008).   Zebrafish 63 
CYP1D1 and CYP1A share a relatively high percent identity and have similar gene structures. 64 
However, neither PCB126 nor TCDD induced transcription of zebrafish CYP1D1.  CYP1D1 65 
protein is expressed in zebrafish liver, and heterologously expressed CYP1D1 is catalytically 66 
active with ethoxyresorufin, albeit at significantly lower rates than CYP1A (Goldstone et al., 67 
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2009). It is possible that chemicals and receptors other than AHR are involved in regulating these 68 
various CYP1s, and that they act on distinct sets of substrates, which could vary among species.  69 
To date, all five CYP1s have been examined in detail only in zebrafish. We sought to 70 
determine if the identity of the full suite of CYP1 genes occurs and is similarly regulated in the 71 
Atlantic killifish Fundulus heteroclitus.  This species is one of the most abundant estuarine fishes 72 
along the Atlantic coast of North America, and frequently is used in toxicological studies, 73 
including developmental toxicology and environmental carcinogenesis (Burnett et al., 2007).  74 
Biological and ecological features (small size, rapid development, small home range, tolerance 75 
of varied conditions) and adaptation to high levels of contaminants have spurred interest in this 76 
species as an alternative non-mammalian vertebrate model species (Burnett et al., 2007; Matson 77 
et al., 2008). 78 
Regulation of CYP1A-like activities has been studied in F. heteroclitus for 30 years (e.g., 79 
Stegeman, 1978) and CYP1A was cloned a decade ago (Morrison et al., 1998). More recently, a 80 
killifish CYP1C1 was reported (Wang et al., 2006).  Here, we report on the identification and 81 
cloning of the full-length sequences of three new F. heteroclitus CYP1 genes, CYP1B1, CYP1C2, 82 
and CYP1D1.  Basal expression and regulation by the AHR agonist PCB126 were compared in 83 
different organs for the three new genes, and for CYP1A and CYP1C1.  It appears that 84 
orthologous CYP1 genes are similarly expressed in Fundulus and in zebrafish.   Identifying 85 
substrates of the CYP1s in this model will help to achieve a general understanding of their 86 
involvement in chemical effects and their roles in endogenous functions, and may contribute to 87 
understanding the resistance to AHR agonist toxicity seen in some populations.   88 
 89 
 90 
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2. Materials and Methods 91 
2.1 Fish collection and maintenance 92 
 Killifish were obtained from Scorton Creek (Massachusetts, USA) in May 2008, using 93 
minnow traps.  Scorton Creek has been used as a reference site for studies of F. heteroclitus for 94 
years (Bello et al., 2001).  Fish were acclimated at 20 °C in flowing seawater for one month and 95 
were fed twice a day with Omega One Freshwater FlakesTM during the acclimation period.  The 96 
procedures used in these experiments were approved by the Animal Care and Use Committee of 97 
the Woods Hole Oceanographic Institution. 98 
2.2 Cloning of new CYP1s 99 
Liver, brain and eye were dissected from one randomly selected untreated fish.  Total RNA 100 
was isolated using AurumTM Total RNA Fatty and Fibrous Tissue Kit (Bio-Rad Laboratories 101 
Inc., Hercules, CA), which includes elimination of genomic DNA by DNAse treatment. The 102 
RNA quantity and quality was determined spectrophotometrically (Nanodrop ND 1000; 103 
NanoDrop Technologies, Wilmington, DE).  cDNA was synthesized from 2 µg of total RNA, 104 
using the Omniscript Reverse Transcriptase kit (Qiagen Inc., Valencia, CA), anchored oligo(dT) 105 
primer (MWG Biotech, Inc., High Point, NC) and RNasin RNase inhibitor (Promega Corp., 106 
Madison, WI).  107 
 Degenerate primers were designed using highly conserved regions of CYP1B1 and 108 
CYP1D1 sequences from other fish species (Supplemental Table 1), avoiding conserved regions 109 
present in other CYP1 subfamilies. Gene-specific primers for CYP1C2 were designed against a 110 
sequence fragment in GenBank. PCR reactions were carried out for CYP1B1 and CYP1C2 using 111 
brain cDNA and for CYP1D1 using liver cDNA.  PCR products were resolved on a 1% agarose 112 
gel and then isolated, ligated into the pGEM-T Easy Vector (Promega), and transformed into 113 
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E.coli (TOP 10 Kit, Invitrogen).  Plasmids were purified from cultures of positive clones 114 
(QiaPrepTM, Qiagen) and were sequenced (MWG Biotech).   115 
The 5’ and 3’ ends of CYP1B1, CYP1C2 and CYP1D1 were obtained by rapid 116 
amplification of cDNA ends (RACE) with the BD SmartTM RACE cDNA Amplification Kit 117 
(Clontech) using the RACE kit and gene-specific primers described in Supplemental Table 1.  118 
Gel-purified 3’ and 5’ RACE products were cloned and sequenced as described above.  119 
Nucleotide sequences were translated and aligned with other CYP1 family members as 120 
before (Jönsson et al., 2007b; Goldstone et al., 2009).  Predicted medaka (Oryzias latipes) and 121 
stickleback (Gasterosteus aculeata) CYP1 gene sequences were derived from the Ensembl 122 
genomes (Release 49).  Phylogenetic trees were constructed by analyzing predicted amino acid 123 
sequences using maximum likelihood (RAxML 7.0.3; (Stamatakis, 2006b)), and Bayesian 124 
methods (MrBayes 3.1.2 (Ronquist and Huelsenbeck, 2003)). Regions of alignment uncertainty 125 
were excluded from phylogenetic analysis (Kreil and Ouzounis, 2003) by automatic masking 126 
using a custom-written script. The WAG-CAT model of amino acid substitution with a gamma 127 
distribution of substitution rates (PROTMIXWAG) was used in all likelihood analyses, based on 128 
likelihood tests using RAxML (Stamatakis, 2006a). MrBayes estimates posterior probabilities 129 
using Metropolis-Hastings coupled Monte Carlo Markov chains (MC3).  MC3 estimates were 130 
performed with the WAG model of amino acid substitution and prior uniform gamma 131 
distributions approximated with four categories (WAG+I+). Four incrementally heated, 132 
randomly seeded Markov chains were run for 3x106 generations, and topologies were sampled 133 
every 100th generation.  Burn-in value was set to 106 generations.  Putative functional domains 134 
(i.e., representing substrate recognition sites) were evaluated for similarity to domain sequences 135 
in orthologous CYP1 genes in other species. The amino acid sequence similarities between 136 
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various CYP1s were plotted using GCG (v. 10.3; Accelrys, San Diego, CA).  Similarity scores 137 
were calculated using the BLOSUM62 amino acid similarity matrix (Henikoff and Henikoff, 138 
1992). 139 
2.3 Experimental Treatment 140 
Twenty male fish (3-5 g whole body weight) were acclimated for 24 hr in recirculating, filtered 141 
and aerated water in two 10-gallon aquaria (10 fish per aquaria) at 18 °C.  After acclimation the 142 
fish were weighed and 10 fish were injected intraperitoneally with 3,3',4,4',5-143 
pentachlorobiphenyl (PCB126) dissolved in DMSO at the dose of 31 pmol/g fish (10 µg/kg fish).  144 
Ten fish were also injected with an equivalent volume of DMSO alone. Previous studies in our 145 
laboratory using scup (Stenotomus chrysops), showed that injection of this PCB126 dose caused 146 
high-level induction in gene expression and catalytic function (EROD) of CYP1A with absence 147 
of mortality (unpublished). The same PCB126 dose was also injected in pink snapper (Pagrus 148 
auratus) in another study, which gave similar results in CYP1A induction (Tugiyono, 2002). At 149 
48 hrs after injection, control and PCB126 treated fish were killed by cervical transection and 150 
liver (n = 10), gill (n = 8), gut, heart, kidney, eye, brain, and testis (n = 4) of individual fish were 151 
dissected and immediately placed in RNAlater (Ambion). The samples were held for 24h at 4 °C, 152 
and then stored at -20 °C. Previous studies in our lab showed higher induction of CYP1A gene 153 
expression in fish exposed to AHR agonists using 48hs exposure. This was also observed by Kim 154 
et al. (2008) who tested a variety of exposure times, and analyzed CYP1A in different pufferfish 155 
organs.  156 
2.4 Quantification of CYP1 Transcripts 157 
Total RNA was extracted and cDNA was synthesized as described above. Gene-specific 158 
primers for the new F. heteroclitus CYP1s and for F. heteroclitus CYP1A, CYP1C1, and β-actin 159 
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designed with Primer3 (Rozen and Skaletsky, 2000) were obtained from MWG Biotech (Primer 160 
sequences are shown in Table 1).  Real-time PCR was performed using iQ SYBR Green 161 
Supermix (according to the manufacturer’s instructions) and an iQ Real-Time PCR Detection 162 
System (Bio-Rad). For each sample, gene expression was analyzed in triplicate with the 163 
following protocol: 95°C for 3 min and 40 cycles of 95°C for 15 s and 62°C for 1 min. Melt 164 
curve analysis was performed on the PCR products at the end of each PCR run to ensure that a 165 
single product was amplified. The Ect method was used to compare the expression levels of the 166 
different CYP1s within a given organ, and to calculate changes in fold-induction in response to 167 
PCB126 treatment.  The efficiency of the PCR reactions for each gene was calculated using the 168 
standard curves generated from dilutions (10 2 – 10 9 molecules) of plasmid (pGEM-T Easy 169 
Vector) containing fragments of a given target gene (Schmittgen and Livak, 2008). Jönsson et al. 170 
(2007b) compared data normalized to different house-keeping genes (-actin or ARNT) using the 171 
Ect method and showed that results differ between these normalizations. Organ-specific 172 
differences in Ct values for β-actin and other reference genes in fish have been shown before 173 
(McCurley and Callard, 2008), and produce conflicting qPCR results when using the ct 174 
housekeeping – ct target normalizing method.  Therefore, to compare relative expression levels between 175 
different organs, molecule numbers for CYP1s and β-actin were calculated based on standard 176 
curves and relative CYP1 transcript abundance was determined for a specific amount of total 177 
RNA from each organ using β-actin only as an efficiency control to normalize individual 178 
samples within a specific organ, but not among different organs. 179 
2.5 Statistics 180 
Equality of variance was tested, accepting P>0.05 (Bartlett's test) (Prism 4, GraphPad 181 
Software Inc., San Diego, CA). Data were logarithmically transformed to improve equality of 182 
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variances. The differences among transcript levels for CYP1s in different organs were evaluated 183 
using one-way analysis of variance (ANOVA, P<0.05), followed by Tukey’s test for multiple 184 
comparisons (Prism 4, GraphPad Software Inc., San Diego, CA). Differences between the means 185 
of control and PCB126 treated groups were analyzed using Student’s t-Test and data are 186 
presented as fold difference between treated and control groups.   187 
   188 
3. Results  189 
3.1 Cloning of CYP1B1, CYP1C2 and CYP1D1 transcripts in F. heteroclitus. 190 
Using degenerate primers based on CYP1B1 and CYP1D1 in other teleosts, we were able 191 
to amplify partial sequences (about 700 bp) from F. heteroclitus.  Aligning the amino acid 192 
sequences predicted from these cloned PCR products with other fish CYP1 amino acid 193 
sequences resulted in preliminary classification of the new Fundulus sequences as CYP1B1 and 194 
CYP1D1.   195 
The alignment of fish CYP1s included a predicted translation of a 588 bp sequence 196 
obtained from GenBank (Accession AF235140) that was annotated as F. heteroclitus CYP1B1.  197 
However, alignment of the predicted amino acid sequence with other CYP1 sequences indicated 198 
that this 588 bp sequence was likely a CYP1C2, and not a CYP1B1.  This putative CYP1C2 199 
sequence and the cloned fragments of the other two genes were used as starting points for full-200 
length sequencing using PCR reactions primed with RACE and gene specific primers.   Full-201 
length sequences were obtained for all three genes (GeneBank accession FJ786959, FJ786960 202 
and FJ786961, respectively).  203 
 204 
3.2 Sequence analysis  205 
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The open reading frames for the three new Fundulus genes give translated proteins of 537, 206 
524 and 535 amino acids, 10-15 amino acids longer than the corresponding zebrafish CYP1B1, 207 
CYP1C2, and CYP1D1, respectively (Supplemental Figure 1). The full-length killifish 208 
sequences display 61%, 69% and 67% pair-wise identity to CYP1B1, CYP1C2 and CYP1D1 of 209 
zebrafish, respectively, increasing to 69%, 74%, and 75% identity when ambiguously-aligned 210 
regions of a large set of CYP1s are masked (Table 2).  Notably, our annotation of these 211 
subfamilies and genes is in agreement with the CYP classification based on the amino acid 212 
percent identities suggested by (Nelson et al., 1996), accepting identities higher than 55 % for the 213 
same subfamily.    214 
Phylogenetic analysis of the deduced amino acid sequences for the five F. heteroclitus 215 
CYP1s was done together with members of the CYP1 family from zebrafish and other selected 216 
species.  These include medaka and stickleback, where five CYP1 sequences were found in their 217 
genomes.  Figure 1 shows that the killifish sequences clustered with the other teleost CYP1s, 218 
with the CYP1As and CYP1D1s appearing in one clade, and the CYP1B1s and the CYP1Cs 219 
occurring in another.  In all cases, the F. heteroclitus CYP1s clustered most closely with the 220 
predicted CYP1 orthologues of medaka.  Interestingly, as in previous analyses (Goldstone et al., 221 
2007; Goldstone et al., 2009), in this analysis zebrafish CYP1C1 and CYP1C2 clustered together 222 
rather than with their respective orthologues.  This general result may be due to gene conversion, 223 
as seen in avian CYP1As (Goldstone and Stegeman, 2006), although the taxonomic sampling of 224 
the CYP1Cs is not yet sufficient to conclude this with any certainty. 225 
In general, the corresponding CYP1s in Fundulus and zebrafish exhibit high degrees of 226 
amino acid sequence similarity (Supplemental Figure 2).  However, this similarity varied along 227 
the length of the proteins, with the lowest similarities (BLOSUM62-based score) observed in the 228 
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membrane anchor, D helix, and the disordered H-I loop regions. The substrate recognition sites 229 
(SRS) of the orthologous zebrafish and Fundulus CYP1s are 74-84% identical, with SRS 2 and 3 230 
displaying the largest number of differences (Figure 2).  Comparisons of F. heteroclitus CYP1A 231 
and CYP1D1 sequences along the length of the proteins showed a marked likeness between 232 
CYP1A and CYP1D1 in SRSs 4 and 5 and a marked difference in SRSs 2 and 3 (Figure 3).  233 
These results are similar to the variation in sequence similarities observed between zebrafish 234 
CYP1A and CYP1D1 (Goldstone et al., 2009). 235 
 236 
3.3 CYP1 transcript expression in organs of F. heteroclitus 237 
Figure 4 shows the differences in expression levels among the CYP1 genes in a given 238 
organ. Relative levels of expression are calculated and expressed as  ct β-actin - ct target. In liver, 239 
heart, kidney, gut, eye and gill, CYP1A was the highest expressed transcript. In liver, CYP1A was 240 
300 times higher than CYP1D1, 1,300 times higher than CYP1B1 and CYP1C1, and 30,000 241 
times higher than CYP1C2. In brain, CYP1B1 and CYP1D1 were the most highly expressed 242 
transcripts. In testis, CYP1C1 was the most highly expressed transcript, 1,000 and 3,000 times 243 
higher than CYP1A and CYP1B1, respectively. CYP1C2 was expressed at the lowest levels 244 
among the five CYP1 genes in most of the organs examined (liver, heart, kidney, eye, brain and 245 
kidney).  246 
Figure 5 shows relative transcript levels of the five CYP1s measured by qPCR, comparing 247 
the levels of a given gene in the eight organs we sampled from control fish: liver, kidney, gut, 248 
heart, gill, eye, brain and testis.  The analysis shows that the highest levels of CYP1A transcript 249 
were observed in liver.  Levels of CYP1B1 transcript were similarly high in brain, heart, gill, eye 250 
and kidney. Earlier studies observed differences in the basal levels of two reference genes, β-251 
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actin and ARNT2, among the different organs (Jönsson et al., 2007b). Thus, in order to avoid 252 
erroneous comparisons of specific CYP1 transcripts between different organs based on a given 253 
reference gene, we calculated transcript abundances based on standard curves.  Individual sample 254 
correction for β-actin levels were organ-specific to allow for CYP1 transcript comparison among 255 
organs.  The highest levels of both CYP1C1 and CYP1C2 were in kidney, and of CYP1D1 were 256 
in brain and kidney. The lowest levels of CYP1A were observed in testis, brain and eye; CYP1B1 257 
in testis, gut and liver; CYP1C1 and CYP1C2 in liver and gill; CYP1D1 in liver and gut. CYP1C1 258 
and CYP1C2 showed generally similar patterns of basal expression levels among organs. 259 
 260 
3.4 PCB126 effects on CYP1 expression  261 
 No mortality was observed in F. heteroclitus injected with PCB126 or the carrier DMSO. 262 
PCB126 induced the expression of CYP1A and CYP1B1 in all eight organs we examined (liver, 263 
heart, kidney, gut, eye, brain, gill and testis) (Figure 6).  The most substantial changes in CYP1 264 
expression in response to PCB126 were in liver, where CYP1C1 was induced ~500-fold and 265 
CYP1B1~200-fold, and in testis, where CYP1A was induced ~700-fold.   CYP1B1 in liver and 266 
gut, CYP1A in brain and CYP1C1 in gill also were induced strongly (~100-fold in each case).   267 
CYP1C1 also was induced in all organs except testis. Although CYP1C1 and CYP1C2 268 
had similar transcript profiles in the different organs of control fish, CYP1C2 was much less 269 
responsive to PCB126 compared with CYP1C1.  Strikingly, in contrast to the other four genes, 270 
CYP1D1 was not significantly induced by this dose of PCB126 in any of the organs examined.   271 
 272 
4. Discussion 273 
4.1 Identification of new CYP1 genes in Fundulus heteroclitus  274 
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With the cloning and sequencing of three new CYP1 genes the CYP1 family in F. 275 
heteroclitus is expanded to four subfamilies and five genes, CYP1A, CYP1B1, CYP1C1, CYP1C2 276 
and CYP1D1.  Previously we established that the same set of CYP1 subfamilies and genes occurs 277 
in zebrafish, and that the five zebrafish CYP1s are expressed at the level of transcription 278 
(Jönsson et al., 2007a; Jönsson et al., 2007b; Goldstone et al., 2009).  The five genes in Fundulus 279 
appear to be orthologues of those in zebrafish, and likewise all five are expressed in many 280 
organs. 281 
Molecular phylogenetic analysis shows that Fundulus CYP1A and CYP1D1 are grouped 282 
together in one clade, while CYP1B1 and the CYP1Cs are in another.  This result is fully 283 
consistent with our prior observation that the CYP1Cs and CYP1Bs are sister subfamilies 284 
occurring in one monophyletic clade (Goldstone et al., 2007; Jönsson et al., 2007b) and that the 285 
CYP1As and CYP1Ds are in another (Goldstone et al., 2009).  The common molecular phylogeny 286 
for the CYP1 genes in several species thus supports the hypothesis that the CYP1As and CYP1Ds 287 
diverged from a common CYP1A/CYP1D ancestor, and the CYP1Bs and CYP1Cs from a 288 
common CYP1B/CYP1C ancestor (Goldstone et al., 2007; Goldstone et al., 2009).   289 
Killifish CYP1C1 and CYP1C2 are very closely related phylogenetically.  A similarly 290 
close relationship occurs between CYP1C1 and CYP1C2 genes in fugu (Godard et al., 2005), and 291 
in zebrafish, where the two genes are located immediately adjacent to one another on 292 
chromosome 17 (Jönsson et al., 2007b).  These observations suggest that the two CYP1C 293 
paralogs resulted from an independent duplication subsequent to a divergence of the CYP1B and 294 
CYP1C lines.  Further, the observations are consistent with the idea that this gene duplication 295 
occurred subsequent to the branching of fishes from the vertebrate line, and that it occurred more 296 
recently than the whole genome duplication thought to have taken place in the fish lineage.   297 
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The phylogenetic analyses also show that the killifish CYP1 sequences are more closely 298 
related to the CYP1 sequences in medaka and stickleback than to those in zebrafish. These 299 
similarities could be expected, since zebrafish is in the superorder Ostariophysi while medaka, 300 
stickleback and Atlantic killifish are in the superorder Acanthopterygii. These two superorders 301 
were separated about 290 million years ago, while orders Beliniformes (medaka) and 302 
Cyprinodontiformes (Atlantic killifish) were separated more recently, around 153 million years 303 
ago (Steinke et al., 2006).   304 
4.2 CYP1 expression in F. heteroclitus   305 
When compared to other CYP1s, higher levels of CYP1A transcript were observed in 306 
most of the organs analyzed, except brain and testis.  Relatively higher levels of CYP1A were 307 
also observed in the organs of abdominal cavity (e.g. liver, kidney and gut) in zebrafish, and 308 
could be associated with the role of these organs in nutrient uptake and processing of body waste 309 
products, e.g., detoxification of endogenous metabolites and food-derived AHR agonists 310 
(Jonsson et al., 2007b).  Although CYP1A was the most abundant transcript in eye and heart, 311 
CYP1B1 and CYP1C1 were also expressed in substantial levels in these organs. Yin et al. (2008) 312 
showed that the basal level of CYP1B1 in zebrafish embryos is regulated by an AHR2-313 
independent pathway, and that CYP1B1 is not directly involved in pericardial edema generated 314 
by dioxin toxicity.  It is well known that CYP1B1 is important for normal eye development in 315 
mammals (Choudhary et al., 2006) and that mutations in this gene are correlated with glaucoma 316 
in human populations (Ohtake et al., 2003).  The physiological importance of CYP1B1 and 317 
CYP1C1 basal levels in the adult fish eye and heart remains to be elucidated.  318 
Similar to the present study, previous studies have shown greater levels of CYP1B1 and 319 
CYP1D1 expression in brain of adult zebrafish compared to the other CYP1s (Jönsson et al., 320 
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2007b; Goldstone et al., 2009).  In developing zebrafish CYP1B1 expression was seen in the 321 
brain before hatching (Yin et al., 2008).  In rat brain as well the basal levels of expression of 322 
CYP1B1 were higher than CYP1As, in four distinct regions of the brain (Desaulniers et al., 323 
2005). While both CYP1B1 and CYP1D1 are expressed in brain the significance of this 324 
expression to brain function is unknown.  The relatively higher levels of CYP1B1 expression in 325 
brain suggest that these CYP1s could play particular roles in this organ in vertebrates including 326 
fish and mammals. The same may be true for CYP1D1 in species where this gene is expressed 327 
(see below).   328 
High levels of all five CYP1s were observed in kidney. CYP1C1, CYP1C2 and CYP1D1, 329 
were particularly high when compared to their levels in other organs.  There could be an 330 
important function for those CYP1s in detoxification; high levels of gene expression for many 331 
phase-I, II and III biotransformation enzymes, as well as receptors involved in the regulation of 332 
those genes, are observed in the kidney and participate in the elimination of many xenobiotics, 333 
drugs and endogenous compounds (Xu et al., 2005). 334 
Comparing the levels of expression of each CYP1 in different organs of killifish showed 335 
similar patterns for the two CYP1Cs, with higher levels in kidney, brain and testis, and lower 336 
levels in liver and gill.  The relative levels of expression of CYP1C1 in kidney, liver, testis and 337 
eye observed by Wang et al., (Wang et al., 2006), in a different population of F. heteroclitus, are 338 
similar to the CYP1C results presented here.  However, while there are similarities in the organ-339 
specific patterns of expression of the CYP1Cs, CYP1C2 was expressed at much lower levels than 340 
CYP1C1.  Thus, the two CYP1Cs could be regulated by similar organ-specific pathways, but 341 
may yet function differently in a given organ.   342 
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The determination that these five CYP1s are expressed in Fundulus as they are in 343 
zebrafish is important, perhaps especially so in the case of CYP1D1.  This is because in humans 344 
CYP1D1 is a pseudogene (CYP1D1P) (Goldstone et al., 2009) and it appears to be a pseudogene 345 
in some other species as well (unpublished data), and thus, finding a CYP1D1 gene does not 346 
necessarily mean that it will be expressed.  The CYP1D1 locus may have been lost from the 347 
genome of still other species, including some fish; we have been unable to detect a CYP1D in 348 
pufferfish genomes.  In some species CYP1D1 functions may be accomplished by other CYPs, 349 
possibly other CYP1s. It will be interesting to determine whether CYP1D1 has unique substrate 350 
specificities.   351 
Generally, it appears that there are catalytic similarities among fish CYP1As. The 352 
substrate specificities of the other CYP1s in Fundulus are not yet known, and are only poorly 353 
known in zebrafish.  We have expressed the five zebrafish CYP1s in yeast, and determined that 354 
the zebrafish CYP1Cs and CYP1D1 act on some of the same alkoxyresorufin substrates that are 355 
oxidized by CYP1A (Goldstone et al., 2009 and unpublished).  In the eel Anguilla japonica, 356 
CYP1C1 appears to metabolize the CYP1A substrates 7-ethoxyresorufin and 7-ethoxycoumarin, 357 
although with lower enzymatic activity than CYP1A.  Interestingly, there were differences 358 
between the eel CYP1A and CYP1C1 in the products formed from one substrate; eel CYP1C1 359 
produced two products from flavanone whereas CYP1A produced just one (Uno et al., 2008).  360 
Studies with heterologously-expressed enzymes can indicate substrate specificities of the 361 
different CYP1s.  However, to understand the role of a particular CYP in a given organ will 362 
require determining the levels of protein expressed, and contributions to substrate turnover by 363 
use of specific inhibitors, or inhibitory antibodies.  We have obtained antibodies to zebrafish 364 
CYP1D1 and have determined that CYP1D1 protein is expressed in zebrafish liver (Goldstone et 365 
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al., 2009).   Unfortunately, the antibodies to zebrafish CYP1D1 do not recognize a protein in 366 
Fundulus liver (unpublished data). Determining the catalytic function of the various CYP1s with 367 
multiple substrates will be essential to establishing the physiological roles of these enzymes.  At 368 
present this would be merely a matter of speculation.  However, the expression patterns suggest 369 
to us that these enzymes will be shown to have distinct physiological roles in fish.  370 
 371 
4.3 Response of CYP1s to PCB126 in F. heteroclitus  372 
The five CYP1s in killifish differed in their responses to treatment of the animals with the 373 
potent AHR agonist PCB126.  The observation that CYP1A is induced in all organs was 374 
expected.  Previous studies have shown that CYP1A in fish is induced to high levels of 375 
expression in detoxification organs (e.g., liver, gastrointestinal tract, gill and kidney), and that 376 
CYP1A is induced in some cell types, often in endothelium, in all organs (e.g., Smolowitz et al., 377 
1992). Immunohistochemical studies have also shown that CYP1A protein levels are strongly 378 
induced in all organs of Fundulus exposed to AHR agonists (VanVeld et al., 1997). The present 379 
study also shows that CYP1B1 was induced in all organs examined. The most significant changes 380 
in CYP1 expression in response to PCB126 were induction of CYP1A (~700-fold) in testis and 381 
induction of CYP1C1 (~500-fold) in liver. CYP1B1 in liver and gut, CYP1A in brain and 382 
CYP1C1 in gill also were strongly induced (>100-fold). Low basal levels of the respective CYP1 383 
gene expression, together with a strong induction by AHR agonists, could explain the higher 384 
fold-increases over control values observed in some organs.  385 
In contrast to CYP1A, CYP1B1 and CYP1C1, expression of CYP1C2 transcript was 386 
weakly induced, and only in three of the organs analyzed (liver, heart and gill). The lesser 387 
responsiveness of CYP1C2 to a potent AHR agonist is reminiscent of the results obtained with 388 
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zebrafish, in which the responsiveness of CYP1C2 to PCB126 was largely absent from adults 389 
(Jönsson et al., 2007a; Jönsson et al., 2007b).  The similarity of results observed in killifish and 390 
zebrafish, even considering that there were different exposure routes for PCB126 in the 391 
experiments with adult fish, suggest a silencing of the induction response of CYP1C2 in adults of 392 
these fish species.   Distinct from the other CYP1s, CYP1D1 was not induced in any of the eight 393 
organs we examined here. In like fashion, there was no induction of CYP1D1 in zebrafish adults 394 
treated with PCB126 or TCDD (Goldstone et al., 2009).  395 
It might be argued that response of CYP1s in Fundulus embryos could differ from that in 396 
adults.  In zebrafish, the only notable difference between adult and embryonic responses to 397 
PCB126 was that CYP1C2 was induced in zebrafish embryos.  However, in zebrafish the 398 
responsiveness of CYP1C2 to PCB126 decreased with developmental age.  The developmental 399 
pattern of expression and the response of the five CYP1 genes to AHR agonists during 400 
embryonic development in Fundulus is under investigation.   401 
The mechanism involved in the lesser induction response of CYP1C2 in adult fish is not 402 
known.  However, the lack of induction of CYP1D1 in zebrafish was suggested to be related to a 403 
lack of functional AHR response elements (AHREs), which are binding sites for the AHR 404 
/ARNT in the promoter regions (Goldstone et al., 2009).  In zebrafish, there are only two 405 
putative AHREs (of unproven function) in the promoter of zebrafish CYP1D1, in contrast to the 406 
22 putative AHREs and three proven functional AHREs for CYP1A (ZeRuth and Pollenz, 2007; 407 
Goldstone et al., 2009).  A variety of other response elements were identified in the promoter 408 
region of zebrafish CYP1D1 (Goldstone et al., 2009) and thus the possibility of induction via 409 
other receptors and agonists still remains to be elucidated, both for the CYP1Cs and CYP1D1 in 410 
Fundulus and in zebrafish.   411 
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The induction of CYP enzymes in fish liver was first suggested as an indicator of aquatic 412 
contamination in the 1970s (e.g., Payne, 1976).  Since then, many studies have shown that 413 
CYP1As in vertebrate liver (often measured by activity assay and protein detection by Western 414 
blot) are strongly induced by some organic contaminants that represent risk for human and 415 
wildlife (e.g., PAHs, coplanar PCBs, polychlorinated dibenzofurans, and dibenzodioxins) 416 
(Bucheli and Fent, 1995).  The results of the present study, along with the results of Wang et al., 417 
(Wang et al., 2006), suggest that in addition to CYP1A, other CYP1s, notably CYP1B1 and 418 
CYP1C1, have potential to be additional sensitive biomarkers of exposure to AHR agonist 419 
contaminants in F. heteroclitus and likely other fishes. Lesser responsiveness by CYP1C2 in 420 
adults and the lack of CYP1D1 induction by potent AHR agonists in two different species 421 
suggests that these two genes would not be suitable markers for exposure to such chemicals.  422 
Nevertheless, CYP1C2 and CYP1D1 may still be involved in the toxicity of AHR agonists or 423 
other chemicals, if such chemicals are substrates for these enzymes, or if these enzymes have 424 
important endogenous substrates and are inhibited by xenobiotics. Thus, all five CYP1 isoforms 425 
could be involved chemical effects, and perhaps in the resistance to AHR agonist toxicity 426 
observed in some Fundulus.  Studies of the expression of the five CYP1 genes are under way in 427 
F. heteroclitus populations that have developed resistance to toxic effects of and a lack induction 428 
of CYP1A by halogenated AHR agonists (Elskus et al., 1999; Bello et al., 2001) .  429 
In summary, we identified and cloned three new CYP1 genes, CYP1B1, CYP1C2 and 430 
CYP1D1, in the Atlantic killifish Fundulus heteroclitus, a vertebrate model used extensively in 431 
environmental toxicology studies. Substantial differences in the levels of expression for the five 432 
CYP1s were observed in the examined organs. We also showed that these CYP1s differ in the 433 
response to the potent AHR agonist PCB126. The organ-specific differences in basal levels, and 434 
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in fold-induction by PCB126, suggest that regulatory mechanisms for the five CYP1 genes could 435 
differ.  Finally, these new CYP1 family members increase the set of potential biomarkers of 436 
aquatic contamination in fish, and may aid in elucidating possible mechanisms of toxicity of 437 
AHR agonists, and the physiological roles of this important gene family.   438 
 439 
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Figure captions: 448 
Figure 1. Phylogenetic tree of selected CYP1 amino acid sequences. In all cases the Fundulus 449 
sequences cluster most closely with the medaka sequences, as expected based on taxonomic 450 
relationships. Numbers at the nodal points are support values derived from Bayesian 451 
phylogenetic and maximum likelihood bootstrap analyses (3x106 generation and 100 replicates, 452 
respectively; Bayes/ML support). Sequences presented in this phylogenetic tree include 453 
predicted sequences for medaka (MEDAKA) and stickleback (GASAC), as well as new and 454 
previously published sequences for killifish (FUNHE), zebrafish (DANIO), human (HOMO) and 455 
mouse (MUSMU). See supplemental data for accession numbers and references. 456 
Figure 2.  Alignment of substrate recognition sites (SRS 1-6) of Fundulus heteroclitus (FUNHE) 457 
and zebrafish Danio rerio (DANRE) CYP1. Residues that are identical to Fundulus CYP1A 458 
sequence are indicated by a dot.  459 
Figure 3.  Similarity between CYP1A and CYP1D1 protein sequence in Fundulus heteroclitus 460 
using a BLOSUM62-based score. A 10-residue running average similarity is displayed. The 461 
substrate recognition sites (SRS) are indicated with a yellow bar. Helix and sheet designations 462 
are marked below the figure by red and blue, respectively. 463 
Figure 4.  Comparison among different CYP1 transcript levels of Fundulus heteroclitus from 464 
control group in a given organ: liver, heart, kidney, gut, eye, brain, gill or testis.  Equal letters 465 
indicate absence of difference among groups (ANOVA – Tukey HSD, p<0.05; n=4-10). Relative 466 
levels for CYP1 transcripts were determined by qPCR using the ECt method and beta-actin as 467 
housekeeping gene (see Methods). Data are presented in a logarithmic scale.  468 
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Figure 5.  Organ-specific expression of CYP1A, CYP1B1, CYP1C1, CYP1C2 or CYP1D1 in 469 
control Fundulus heteroclitus. Equal letters indicate absence of difference among organs for a 470 
given CYP1 (ANOVA – Tukey HSD, p<0.05; n=4-10). Levels for CYP1 and beta-actin gene 471 
expression were determined by qPCR using standard curves. Beta-actin was employed to 472 
normalize individual gene expression within but not between each organ group. Gene expression 473 
is presented as relative levels.  474 
Figure 6.  Fold induction of CYP1s 48-hours after injection with PCB 126 (31 nmol/g fish) 475 
relative to fish injected with DMSO (control) in Fundulus heteroclitus. Analyses were done in 476 
liver, heart, kidney, gut, eye, brain, gill or testis. The numbers of molecules for CYP1 transcripts, 477 
as well as for the housekeeping gene beta-actin, were determined by qPCR using standard 478 
curves. (*p<0.05, **p<0.005 and ***p<0.001, comparison between control and PCB injected 479 
groups using Student’s t-Test; n=4-10).  480 
 481 
 482 
 483 
 484 
 485 
 486 
 487 
 488 
 489 
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Table 1. Primers employed in the CYP1A, CYP1B1, CYP1C1, CYP1C2, CYP1D1 and -actin 668 
qPCR reactions in Fundulus heteroclitus. 669 
primer name Primer sequence 5' - 3' Location 
1A forward CTTTCACAATCCCACACTGCTC 1301 - 1322 
1A reverse GGTCTTTCCAGAGCTCTGGG 1404 - 1423 
1B1 forward ATATTTGGAGCCAGCCAGGACACG 629 - 652 
1B1 reverse CGCACCTGCATCTCAGGGTACTTG 691 - 714 
1C1 forward TCTGGACGCCTTCATCTACGA 1296 - 1316 
1C1 reverse GTGACGTCCGATGTGGTTGA 1360 - 1379 
1C2 forward GCAGGCTGCCATCTGTTGAGGACA 1257 - 1280 
1C2 reverse CGAAGCTGGTGAAACGCATTGTCT 1317 - 1340 
1D1 forward CTTTCACCATCCCTCACTGCACCA 1322 - 1345 
1D1 reverse GTCTCCGGATCACCCCAAAGATCC 1428 - 1451 
β-actin forward TGGAGAAGAGCTACGAGCTCC * 
β-actin reverse CCGCAGGACTCCATTCCGAG * 
     
* no full sequence available    
 670 
671 
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Table 2. Identities between Danio rerio (DANRE) and Fundulus heteroclitus (FUNHE) CYP1 672 
sequences. Values for amino acid identities are presented in the right-top and nucleotide 673 
identities in the left-bottom of the table. Regions of ambiguously aligned sequences were 674 
masked. 675 
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FUNHE_1A  0.73 0.47 0.48 0.41 0.43 0.41 0.40 0.41 0.40 
DANRE_1A 0.70   0.48 0.48 0.42 0.43 0.42 0.42 0.41 0.41 
FUNHE_1D1 0.56 0.56  0.75 0.40 0.40 0.39 0.40 0.41 0.41 
DANRE_1D1 0.56 0.55 0.70   0.38 0.39 0.38 0.40 0.41 0.42 
FUNHE_1B1 0.50 0.51 0.52 0.48  0.69 0.53 0.56 0.53 0.55 
DANRE_1B1 0.51 0.51 0.50 0.48 0.68   0.54 0.56 0.55 0.56 
FUNHE_1C1 0.49 0.50 0.50 0.49 0.61 0.59  0.81 0.70 0.75 
DANRE_1C1 0.49 0.50 0.50 0.51 0.60 0.60 0.72   0.73 0.83 
FUNHE_1C2 0.50 0.49 0.50 0.50 0.59 0.58 0.71 0.69  0.74 
DANRE_1C2 0.49 0.50 0.51 0.51 0.60 0.60 0.69 0.82 0.70   
 676 
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 679 
 680 
 681 
 682 
 683 
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Supplemental data for Zanette et al. “Three new P450 1 genes in the killifish Fundulus 684 
heteroclitus: basal expression and response of the full complement of killifish CYP1s to the AHR 685 
agonist PCB126” 686 
Supplemental Table 1. Degenerate primers employed in the amplification of cDNA fragments 687 
of the new CYP1B1 and CYP1D1 genes and specific primers used for Smart-RACE cloning of 688 
full-length sequences of CYP1C2, CYP1B1 and CYP1D1 in Fundulus heteroclitus. 689 
primer name Primer sequence 5' - 3' Location 
1B1 degenerate forward GCBGGSAGCATCGTGGACGTG 374 - 394 
1B1 degenerate reverse TTGGACAGCTCCTCDCCRATGCA 1058 - 1080 
1D1 degenerate forward GRATGAAYGGATTCATGGAGCGCA 947 - 970 
1D1 degenerate reverse GGTGCYBAGATCCAGCTBCTGACC 1627 - 1650 
1B1 3' forward 1 ATATTTGGAGCCAGCCAGGACACG 629 - 652 
1B1 3' forward 2 CTGCCGTACGTCATGGCCTTCATC 782 - 805 
1B1 5' reverse 1 CCACCGAGAAGATGAGCACGTTG 1024 - 1046 
1B1 5' reverse 2 TCAAATGTCTCCGGGTTGGACCAC 949 - 972 
1C2 3' forward 1 GCAACGGTGGCAGATTTGATCGGCGCAGGC 1121 - 1150 
1C2 3' forward 2 TGACAGGGTGGTGGGGAGAGGCAGGC 1237 - 1262 
1C2 5' reverse 1 TGAGGGTCCTTCCACCTCAGGGGGTCGTG 1442 - 1470 
1C2 5' reverse 2 GGGGGATGGTGACAGGGACGAAGCCGGT 1331 - 1358 
1D1 3' forward 1 GCGCAGGATCCAGGAACACATCAAC 966 - 990 
1D1 3' forward 2 GGGTTGCAGTGGAGCCTGTTGTACCT 1147 - 1172 
1D1 5' reverse 1 CATCTCCAAACGTGCGACTCCATCC 1551 - 1575 
1D1 5' reverse 2 GTCTCTTGTGGTGCAGTGAGGGATGG 1328 - 1353 
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 692 
Supplemental Figure captions for Zanette et al. “Three new P450 1 genes in the killifish 693 
Fundulus heteroclitus: basal expression and response of the full complement of killifish CYP1s 694 
to the AHR agonist PCB126” 695 
Supplemental Figure 1. Alignment of Fundulus heteroclitus (FUNHE) and zebrafish Danio 696 
rerio (DANRE) CYP1s. Substrate recognition sites (SRS 1-6) and the heme-binding domain are 697 
designated by rectangles. A dot indicates residues that are identical to the Fundulus CYP1A 698 
sequence. 699 
 700 
Supplemental Figure 2. Pairwise similarities between Fundulus and zebrafish CYP1 ortholog 701 
pairs of protein sequences using a BLOSUM62-based score. A 10-residue running average 702 
similarity between Fundulus and zebrafish orthologs is presented, with the different zebrafish-703 
Fundulus CYP1 pairwise comparisons offset by cumulative 5 point intervals for presentation 704 
purposes.  705 
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